Skip to main content

MYOK Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

MyoKardia, Inc. News

Bristol-Myers Shares Gain After Positive Data From Opdivo Lung Cancer Trial

Bristol-Myers said its blockbuster drug, Opdivo, as well as chemotherapy helped patients suffering from resectable non-small cell lung cancer in a late-stage trial.

Morning Bell With Jim Cramer: Wait to Buy Regeneron

Jim Cramer shares stock market news about buying Regeneron stock, the Bristol Meyers deal, and Trump’s tweet about a stimulus package.

MyoKardia, Aphria: 5 Top Stock Gainers for Monday

MyoKardia, Eidos Therapeutics, HMS Holding, Aphria and Jen-Weld are five of Monday's top gainers.

Stocks Close Higher; Trump Says He's Leaving Hospital Monday

Stocks end higher after President Trump tweets he's leaving Walter Reed Medical Center on Monday evening.

Is Bristol-Myers a Buy After $13.1 Billion Buy of MyoKardia?

MyoKardia is surging after a takeout deal from Bristol-Myers Squibb, which is marginally higher on the day. Does the deal make Bristol-Myers a buy?

Breaking News

Las Vegas Strip May Lose a Major Sports Franchise

Sin City usually gets what it wants. That may not happen this time.

Steve Jobs Gets Posthumous Award From President Joe Biden

Jobs was one of 17 people to be awarded the Presidential Medal of Freedom.

Target Has a Surprising New Idea For Cereal Fans

This throwback will excite fans who fondly remember cereals from their childhoods.

TikTok Faces a New Major Threat

The popular short-form social media company is in the hot seat once again in the U.S.